Biochemical Engineering


Professor Suzanne Farid

Professor of Bioprocess Systems Engineering

  • Deputy Head of Department (Education)
  • Fellow of Institution of Chemical Engineers (FIChemE) (2011)
  • Chartered Engineer (CEng), Institution of Chemical Engineers (2007)
  • Co-Director, EPSRC Future Targeted Healthcare Manufacturing Hub, UCL (2017-present)
  • Director, UCL-MedImmune Centre of Excellence (2014-present)
  • Co-Director, EPSRC Centre for Innovative Manufacturing, UCL (2011-2016)
  • Chair, ECI Conference on Integrated Continuous Biomanufacturing III (ICB III) (Sep  2017) and ICB II (Nov 2015)
  • Member, BIA (BioIndustry Association) Manufacturing Advisory Committee for Bioprocessing Industries (2009 - present)
  • Member, BIA (BioIndustry Association) Cell and Gene Therapy Advisory Committee (2017 - present)
  • Member, ISCT (International Society for Cellular Therapy) Business Models and COGs Subcommittee (2014 - present)
  • Member, IChemE Biochemical Engineering Subject Group (1997 - present)
  • Invited member of MMIP Roadmapping Consultation for Biopharmaceuticals and ATMPs (2016-17) 
  • Invited member of HealthTech and Medicines KTN Roadmapping Consultation to define the Biopharmaceutical and ATMP Manufacturing Technology challenges for the Technology Strategy Board (2012) 
  • Royal Academy of Engineering - ExxonMobil Award for Excellence in Teaching (2009)
  • Medicine Maker Power List – Top 10 Masters of the Bench (2017), Top 100 Most Influential People in Drug Development and Manufacture (2016)

Teaching and Training Activities

Suzanne’s current teaching activities include guiding both Biochemical Engineering and Biotechnology students in their 3rd year Bioprocess Plant Design Project which involves the complete design of a bioprocess plant for the production of biotech products arising out of life science discoveries. She has driven the creation of a new research-led teaching course, Bioprocess Systems Engineering, which exposes Master’s level students to the department’s cutting-edge research in Decisional Tools.  Suzanne’s earlier teaching roles include co-ordination of the following core process engineering courses to undergraduate and MSc students: Fluid Flow & Mixing in Bioprocesses, Heat & Mass Transfer in Bioprocesses and Computer-Aided Bioprocess Engineering. 

Suzanne also co-ordinates the department's MBI® training module on Quality by Design for Effective Bioprocess Characterisation and Validation which forms part of the departments continual professional development (CPD) offering. She teaches on several other MBI® training modules on economic aspects of mammalian cell processes, cell therapy cost of goods analysis, single-use process economics, R&D portfolio decisions and approaches to accelerating bioprocess development.

Dr Suzanne Farid

Prof Suzanne Farid


Room 3.7 (Bernard Katz Building)
Dept Biochemical Engineering


  • Professor of Bioprocess Systems Engineering
    Dept of Biochemical Engineering
    Faculty of Engineering Science

Joined UCL


Specialities: Bioprocess Decisional Tools, Bioprocess Economics, Drug Development Cost Modelling, Capacity planning, Portfolio Management, Risk Analysis, Multi-Criteria Decision-Making, Multi-Objective Simulation & Optimisation, Chemometrics

Suzanne Farid is Professor in Bioprocess Systems Engineering at the Advanced Centre for Biochemical Engineering at University College London (UCL). She is Co-Director of the EPSRC-funded Future Targeted Healthcare Manufacturing Hub in collaboration with industrial and academic consortia to revolutionise the delivery of cost-effective stratified protein-based and personalised cell-based therapies to patients.  She is also Director of the UCL-MedImmune Centre of Excellence on predictive multivariate decision-support tools for mammalian cell manufacturing processes. Previously she was Co-Director of the EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies

She leads research on novel software-based ‘Bioprocess Decisional Tools’ to plan the best route to manufacture of new biotherapeutic candidates. More specifically, she has pioneered the design of novel algorithms at the process-business interface to facilitate cost-effective bioprocess design, capacity planning, and R&D portfolio management through to predictive tools for root cause analysis and manufacturability assessments.

These tools have been applied to strategic decisions in the development and manufacture of protein biopharmaceuticals such as monoclonal antibodies (mAbs) and of cell and gene therapies (e.g. MSCs, CAR T-cells). Examples include batch versus continuous manufacture, in-house versus contract manufacturing decisions, factory floor scheduling, centralised versus decentralised manufacture of personalised therapies, facility fit prediction and root cause analysis of deviations in critical quality attributes (CQAs). 

Funding for the above research has come from the UK EPSRC and BBSRC Research Councils, Innovate UK (previously the TSB Technology Programme) and a range of company collaborators including Medimmune, GSK, Pfizer, Eli Lilly, Bayer, Lonza Biologics, and Pall Life Sciences. In addition the Future Targeted Healthcare Manufacturing Hub is supported by a User Steering Committee of over 35 industrial users and sector organisations.

Award year Qualification Institution
2001 PhD
Doctor of Philosophy
Biochemical Engineering
University College London
1997 BEng hons
Bachelor of Engineering (Honours)
Biochemical Engineering
University College London
03-05 CLTHE_1
Certificate in Learning and Teaching in HE Part 1
Academic studies in Higher Education
University College London